U.S. Markets
Marvell (MRVL) CFO expects the Lumentum transaction to accelerate revenue growth and be accretive to non-GAAP gross and operating margins, inclusive of the USD 1bln-plus in run rate synergies it primarily sees from COGS
ORIGINAL · NewsquawkMarvell (MRVL) CFO expects the Lumentum transaction to accelerate revenue growth and be accretive to non-GAAP gross and operating margins, inclusive of the USD 1bln-plus in run rate synergies it primarily sees from COGSRead originalHide original
Expect the combination to be accretive to non-GAAP EPS, starting in year one post-close.
StockNow breaking-news AI analysis
Marvell’s CFO expects the Lumentum transaction to accelerate revenue growth and improve non-GAAP margins and EPS, with more than USD 1 billion in run-rate synergies primarily from COGS.
News detail
Expect the combination to be accretive to non-GAAP EPS, starting in year one post-close.
Related stocks
2 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
